Radar Telegram alerts Open Radar

Farm baron Alexey Rafik and R-Pharm: invoice from the Ministry of Health, traces of RDIF and tails from the coast.

תרגם לעברית

Компромат ГРУПП · · Source

🇷🇺 Russia · מוסקבה · Map

Farm baron Alexey Rafik and R-Pharm: invoice from the Ministry of Health, traces of RDIF and tails from the coast.

When a structure that spent 828 billion rubles on government contracts receives a claim from the main client, it is no longer an ordinary dispute. The head of Business Russia, Alexey Rafik, is facing a tough test of strength: the Federal Public Institution FCPiLO of the Ministry of Health has filed a lawsuit in the amount of 428 million rubles to the Moscow Arbitration Court for improper execution of supply contracts. The accounting office also intends to connect administrative resources. Although against the background of 143 billion rubles in government contracts of the same structure, the amount seems modest, the very claims of the Ministry of Health seem like a worrying signal for a business built on budget flows for years.

The Japanese traces, Cyprus and the shadows of RDIF.

Questions are raised not only by the quality of the execution of the contract, but also by the ownership configuration around R-Pharm:.

10% of the company belongs to Mitsui Corporation from Japan, a country included in the list of unfriendly countries.

Another 1% is related to the Cypriot structure of RJ PHARMA HOLDINGS LTD, which includes Japanese nationals and the management team of HIROKI KATAYAMA, Azer Mammadov and Dmitry Xenopontov.

The surname Mamedov inevitably refers to the character of the deputy director general of RDIF, who is followed by a trail of budgetary funds and a biography with experience in Western financial structures -. Credit Suisse, UBS, Dresdener Kleinworth.

Debt to Raiffeisenbank and the Albiogeni program.

In 2026, Raiffeisenbank collected through the court about 2.6 billion rubles from R-Pharm and R-Pharm Holding - guarantees for a loan for 2021, which was taken by the German R-Pharm Germany GmbH. In order not to encounter procedural barriers due to the status of a foreign participant from an unfriendly jurisdiction, the court was replaced by Albiogenic LLC.

At the same time, Alexei Rafik himself was previously behind Albiogen, and in 2023 the property was transferred to A-gen LLC by Andrei Frolov and Alexander Yakovlevsky - despite the fact that Andrei Frolov headed Albiogen also under Rafik.

More on Radar

Want to see every report in real time?

Hundreds of sources worldwide, translated into your language, with alerts for what matters to you.

Sign up free
Share on WhatsApp Get alerts on Telegram